Apollo, Max Healthcare, Yatharth, Other Hospital Share Price Rise Up to 4% on CGHS Revamp Impact

On October 6, 2025, shares of leading Indian hospital chains, including Apollo Hospitals, Max Healthcare, Yatharth Hospitals, and others, recorded gains up to 4% after the government announced a significant revision in Central Government Health Scheme (CGHS) rates. 

This policy revamp marks the first since 2014 and aims to address long-standing concerns of medical inflation and non-functioning cashless treatments.

Hospital Stocks Surge on Rate Hike Under CGHS

Hospital stocks surged after the government revised rates for nearly 2,000 medical procedures under the CGHS, which will become effective from October 13, 2025. Shares of Max Healthcare increased nearly 3%, Yatharth Hospitals gained between 2.5% and 3.5%, and Apollo Hospitals rose by over 2%. This spike comes as investors anticipate better margins for hospitals with a larger share of government scheme patients.

Key Players to Benefit from the Revamp

The revised CGHS model introduces a new rate structure based on 4 parameters, including hospital accreditation, city classification (tier-1, 2, 3), hospital type, and ward entitlement. Accredited hospitals will serve as the base rate, while non-accredited ones will see 15% lower reimbursements. Additionally, hospitals in tier-2 and tier-3 cities will see lower reimbursement rates by 10% to 20% compared to their tier-1 counterparts.

Positive Outlook for Government-Tied Hospitals

Hospitals with significant government scheme exposure are projected to benefit the most. Yatharth has one of the highest exposures at 35%, followed by Max Healthcare at 21.8%, Narayana Health at 18%, Global Health at 18% and Apollo Hospitals at 9%. The revised rates also promise quicker and improved receivables compared to past delays and underpayments.

Read More: Apollo Hospitals Acquires Remaining Stake in Apollo Gleneagles PET-CT!

Reimbursement Issues Addressed After 11 Years

Earlier, patients under CGHS often had to pay out of pocket due to outdated packages that did not reflect the rising cost of healthcare. Patients also faced long delays in reimbursements. The new structure now ties reimbursement to market-aligned rates, bringing relief for both hospitals and citizens relying on CGHS benefits.

Conclusion

The CGHS rate revision has injected optimism across hospital stocks, particularly those holding significant exposure to government-backed schemes. The updated structure is expected to improve hospital margins and reduce past inefficiencies in reimbursements, marking a pivotal moment in India’s public healthcare strategy.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.